Feedback / Questions
tilavonemab (ABBV-8E12) - AbbVie
https://www.mdsabstracts.org/abstract/a-tau-directed-monoclonal-antibody-could-alter-the-tau-pathology-of-progressive-supranuclear-palsy/
G. Beck; R. Yamashita; Y. Yonenobu; K. Ikenaka; S. Murayama; H. Mochizuki
Aug 31, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next